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A Collateral Benefit of Research in Palliative Care
Elizabeth A. Lobb, BAEd, MAppSci, Ph.D.,1 Kate Swetenham, R.N., B.N., GDPsyOnc, M.P.C.2,3
Meera Agar, MBBS, M.P.C., FRACP, FAChPM,3–5 and David C. Currow, BMed, M.P.H., FRACP3
Dear Editor:
A collateral benefit of being in a research-active clinical unit
is that there is evidence that better care is delivered. The most
dramatic data to date demonstrate that in cardiology, re-
search-active cardiology departments in community and
university hospitals deliver better survival than those units
that do not enroll people in clinical trials.1
In hospice and palliative care, Phase III studies are crucial
to improving the quality of evidence for day-to-day practice,
yet acceptance of their role is still limited to a relatively small
number of clinical units. Barriers continue to include beliefs by
clinicians that ‘‘we already know what works’’ and the con-
cern that patients should not be burdened with participation
in studies at the end of life when they have other things about
which to worry. To answer the first concern, an evidence base
derived from case series shows a range of benefit from a 90%
underestimate of effect to a 150% overestimate when non-
randomized studies are compared with subsequent random-
ized clinical trials.2 To answer the second concern, people
want to participate in studies that will improve the quality of
care, and potential participation is higher in palliative care
than many other clinical disciplines.3
In Australia, since 2006 a national clinical trials collabora-
tive funded by theDepartment of Health andAgeing has been
running 8 adequately powered, rigorously designed, double-
blind, randomized controlled Phase III studies across 12
participating sites. The first of these studies has been com-
pleted, whereas the others continue to recruit.4 The primary
aim of the Palliative Care Clinical Studies Collaborative
(PaCCSC) is to generate research data of a quality that would
support the listing of study medicines on the Australian
Register of Therapeutic Goods and subsequent subsidy ap-
plications were the studies to be positive. Additional aims
include building clinical research capacity and developing
further the evidence base for practice and policy related to
hospice and palliative care.
Direct benefits of this collaborative for participating sites
include stronger working links with other palliative care
units, and mentoring of clinical researchers. Detailed Stan-
dard Operating Procedures developed by PaCCSC underpin
every aspect of trial conduct to ensure consistent approaches
to research across all sites. Both Standard Operating Proce-
dures and the clinical trials protocols have the potential to
impact positively on day-to-day clinical care. Research op-
portunities have created new foci on patient and family care.
The Australian Council of Healthcare Standards (ACHS) is
the organization that accredits health care facilities and ser-
vices in Australia on a 4-year cycle of quality improvement to
ensure safe and effective health care is consistently available.
ACHS surveyors conduct onsite visits every 2 years to pro-
vide an independent assessment of each facility’s perfor-
mance against the national standards.
One objective collateral benefit of active participation in
PaCCSC for 3 units recently accredited was the response by
the accreditation team. All sites had other significant clinical
services on campus ranging from rehabilitation to elective
orthopedic surgery. Palliative care, and specifically palliative
care research, was singled out for its excellence at all 3 sites at
the summary meetings with 3 domains highlighted: Clinical
(e.g., care planning and delivery, medications, infection con-
trol), Support (e.g., risk management, incident management,
quality framework, human resources, information technol-
ogy, research), and Corporate (e.g., safe practice and envi-
ronment). Excellence in these 3 areas was attributed to
participation in PaCCSC and was seen to have direct benefits
for day-to-day patient care across the whole clinical unit, not
just for people participating in studies.
For units preparing for accreditation, participation in
PaCCSC provided excellent evidence of quality processes
and the ‘‘virtuous cycle’’ of quality improvement in action.
Comments from the surveyors for accreditation focused
specifically on the results from research and the way in which
research outcomes are informing clinical practice and service
development. Potential improvements in routine clinical
practice include better screening of symptoms, more consistent
evaluation of outcomes after changes in clinical interventions,
and more uniformity in the clinical interventions provided.
The view from surveyors for accreditation, who see a wide
range of services in many health facilities, supports the
importance of seeking better evidence for the routine man-
agement of key palliative care symptoms through well-
designed clinical trials. Their comments on how well clinical
research was embedded into routine practice reinforces that
such studies are feasible, and good research can only improve
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clinical practice and teaching. In the words of the surveyors
for accreditation:
This ‘‘organization is recognized.for its contribution to advancing
clinical change and in expanding the body of industry knowledge
related to palliative care.’’
‘‘The surveyors were impressed with the.use of research relevant to
care planning and delivery.’’
’’Research is well integrated into the palliative care unit.and.
directly related to the model of care and patient outcomes.’’
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